Clinical trials: Intracutaneous Drug Delivery
Hemorrhoidectomy, Postoperative Analgesia
The Impact of Methylene Blue on the Quality of Recovery in Patients Undergoing Hemorrhoidectomy
Classical hemorrhoidectomy is known to be linked with significant postoperative pain, which can result in patient discomfort, extended hospital stays, and increased costs.
- Trial name
- NCT06747195
- Where
- 3 sites in China
- Volunteers
- 290 people
- Sponsor
- Qilu Hospital of Shandong University
Celiac Disease, Intestinal Disease
Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease
A randomized, double-blind, placebo-controlled clinical study in non-homozygous human leukocyte antigen (HLA)-DQ.2.5+ adults with celiac disease (CeD).
- Conditions
- Celiac Disease, Intestinal Disease, Malabsorption Syndromes, Gastrointestinal Disease
- Trial name
- NCT03543540
- Testing
- Nexvax2
- Where
- 3 sites in Australia
- Volunteers
- 14 people
- Sponsor
- ImmusanT, Inc.
Diabetes
A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces
The purpose of this study is to compare two continuous glucose sensors, one placed subcutaneous (under the skin) and one placed intradermal (in the skin) over 12-14 hours.
- Trial name
- NCT01093833
- Testing
- BD Continuous glucose monitor (BD CGM), YSI Glucose Analyzer, Medtronic Guardian CGM
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Becton, Dickinson and Company
HIV Infections, Tuberculosis
Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection
To quantitate in an HIV-infected population the percentage of patients demonstrating the "booster" phenomenon (attainment of a positive response to a second tuberculin purified protein derivative skin test when the first skin…
- Trial name
- NCT00000955
- Testing
- Tuberculin Purified Protein Derivative
- Where
- 14 sites in United States
- Volunteers
- 864 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
CNS Tumor, Adult
Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma
RATIONALE : IMA 950 is multi tumour-associated peptides (TUMAPs) vaccine, these peptides have been identified on primary glioblastoma multiforme (GBM) cells.
- Trial name
- NCT01920191
- Testing
- IMA 950, Poly ICLC, Immunomonitoring
- Where
- Switzerland
- Volunteers
- 19 people
- Sponsor
- University Hospital, Geneva
Diabetes
Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients
The purpose of this study is to compare the effects of bolus delivery of insulin when delivered either intradermally (in the skin) or subcutaneously (under the skin) in diabetics.
- Trial name
- NCT01120444
- Testing
- BD Research Catheter with 34G x 1.5 mm needle, Subcutaneous delivery of insulin using Disetronic Accu-Chek Rapid D infusion set
- Where
- Germany
- Volunteers
- 20 people
- Sponsor
- Becton, Dickinson and Company